サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1656913

埋め込み型BCI (ブレインコンピュータインターフェース) デバイス：市場洞察・競合情勢・市場予測 (～2032年)

Implanted Brain-Computer Interface (BCI) Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

出版日
発行
DelveInsight
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
埋め込み型BCI (ブレインコンピュータインターフェース) デバイス：市場洞察・競合情勢・市場予測 (～2032年)
出版日: 2025年01月01日
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

埋め込み型BCI (ブレインコンピュータインターフェース) デバイスの市場規模は、予測期間中にCAGR 10.42％で成長すると予測されています。

埋め込み型BCI (ブレインコンピュータインターフェース) デバイスの需要は、神経疾患や運動障害の有病率の増加、聴覚や視覚の喪失を経験する患者数の増加によって大きく牽引されています。また、デジタルヘルスソリューションの採用拡大が患者ケアの展望を再構築し、市場成長をさらに促進しています。このような上昇傾向に寄与している主な要因には、より高度なBCIデバイスを開発するための研究開発活動の活発化や、大手企業間の戦略的提携などがあります。こうした市場開拓は、2025年から2032年までの予測期間中、埋め込み型BCIデバイス市場の推進に極めて重要な役割を果たすと期待されています。

埋め込み型BCIデバイスの市場力学：

神経疾患や運動障害の有病率の増加が埋め込み型CIデバイスの市場成長を促進する見通しです。世界保健機関 (WHO) が2024年4月に提供したデータによると、2021年には世界で約1,540万人が脊髄損傷を患っています。

2022年にUK Research and Innovationが提供したデータによると、世界では毎年約1,000万人が外傷性脳損傷の影響を受けています。埋め込み型BCIデバイスは、TBI後の脳機能評価において重要な役割を果たし、脳損傷の程度に関する重要な洞察を提供し、治療の意思決定を導きます。このような神経障害の発生率の増加が、埋め込み型BCIデバイスに対する需要の高まりを生み出し、市場の成長を促進しています。

2024年の世界保健機関 (WHO) の最新データによると、2023年には世界で約5,000万人がてんかんを患っており、毎年約500万人が新たにてんかんと診断されています。てんかんは世界的に最も一般的な神経疾患の1つとなっています。同データによると、2023年には5,500万人以上が認知症を患っており、その60％以上が中低所得国に居住しています。毎年、平均して1,000万人近くが新たに認知症と診断されています。埋め込み型BCIは脳活動をモニターして発作に関連する異常な電気パターンを検出することができ、てんかんをより効果的に管理するのに役立つリアルタイムのデータを提供することができます。このような運動障害の有病率の増加は、市場の成長を促進すると予想されます。

また、聴覚障害や視覚障害の有病率の増加も、埋め込み型BCIデバイスの市場成長を大きく促進すると予想されています。2023年3月の世界保健機関 (WHO) のデータによると、欧州では1億9,000万人以上が難聴を抱えながら生活しており、この数字は2050年までに2億3,000万人を超えると予想されています。埋め込み型BCIデバイスは聴覚を回復させ、聴覚体験を向上させる上で重要な役割を果たします。難聴の罹患者数が増加の一途をたどる中、革新的なBCIデバイスの需要は拡大し、市場拡大をさらに後押しするものと思われます。

当レポートでは、世界の埋め込み型BCI (ブレインコンピュータインターフェース) デバイスの市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 埋め込み型BCI (ブレインコンピュータインターフェース) デバイス市場レポート：イントロダクション

  • 調査範囲
  • 市場セグメンテーション
  • 市場の前提因子

第2章 埋め込み型BCI (ブレインコンピュータインターフェース) デバイス市場：エグゼクティブサマリー

  • 市場概要

第3章 競合情勢

第4章 規制分析

  • 米国
  • 欧州
  • 日本
  • 中国

第5章 埋め込み型BCI (ブレインコンピュータインターフェース) デバイス市場：主要要因分析

  • 市場促進要因
    • 神経疾患および運動障害の増加
    • 聴覚や視覚の喪失を経験する患者数の増加
    • デジタルヘルスソリューションの導入拡大
    • 主要企業間の研究開発活動と戦略的連携の強化
  • 市場抑制要因と課題
    • 埋め込み型BCIデバイスに関連する合併症と安全性の懸念
    • デバイスの高コスト性
  • 市場機会
    • AIと埋め込み型BCIデバイスの統合
    • 低侵襲手術とスマートインプラントの出現

第6章 埋め込み型BCI (ブレインコンピュータインターフェース) デバイス市場：ポーターのファイブフォース分析

第7章 埋め込み型BCI (ブレインコンピュータインターフェース) デバイス市場の評価

  • 製品別
    • ハードウェア
    • ソフトウェア
  • アプローチ別
    • 侵襲的BCI
    • 低侵襲BCI
  • 用途別
    • てんかん
    • 脳損傷
    • うつ
    • 脳卒中
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 埋め込み型BCI (ブレインコンピュータインターフェース) デバイス市場：企業・製品プロファイル

  • NeuroPace, Inc.
  • Blackrock Neurotech
  • Synchron
  • LivaNova, Inc.
  • BrainGate
  • BrainCo, Inc.
  • Cognixion, Inc.
  • Brain Products GmbH
  • Compumedics Neuroscan
  • CorTec
  • Snap Inc.
  • g.tec medical engineering GmbH
  • Bitbrain Technologies
  • Nexstem India Pvt. Ltd.
  • Paradromics
  • CereGate
  • Precision Neuroscience
  • ONWARD Medical N.V.
  • NeuroSky
  • NeuroXess

第9章 KOLの見解

第10章 プロジェクトのアプローチ

第11章 DelveInsightについて

第12章 免責事項・問い合わせ

図表

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Implanted Brain-Computer Interface (BCI) Devices Market in Global (2022-2032)
  • Table 3: Implanted Brain-Computer Interface (BCI) Devices Market in Global by Product (2022-2032)
  • Table 4: Implanted Brain-Computer Interface (BCI) Devices Market in Global by Approach (2022-2032)
  • Table 5: Implanted Brain-Computer Interface (BCI) Devices Market in Global by Application (2022-2032)
  • Table 6: Implanted Brain-Computer Interface (BCI) Devices Market in Global by Geography (2022-2032)
  • Table 7: Implanted Brain-Computer Interface (BCI) Devices Market in North America (2022-2032)
  • Table 8: Implanted Brain-Computer Interface (BCI) Devices Market in the United States (2022-2032)
  • Table 9: Implanted Brain-Computer Interface (BCI) Devices Market in Canada (2022-2032)
  • Table 10: Implanted Brain-Computer Interface (BCI) Devices Market in Mexico (2022-2032)
  • Table 11: Implanted Brain-Computer Interface (BCI) Devices Market in Europe (2022-2032)
  • Table 12: Implanted Brain-Computer Interface (BCI) Devices Market in France (2022-2032)
  • Table 13: Implanted Brain-Computer Interface (BCI) Devices Market in Germany (2022-2032)
  • Table 14: Implanted Brain-Computer Interface (BCI) Devices Market in United Kingdom (2022-2032)
  • Table 15: Implanted Brain-Computer Interface (BCI) Devices Market in Italy (2022-2032)
  • Table 16: Implanted Brain-Computer Interface (BCI) Devices Market in Spain (2022-2032)
  • Table 17: Implanted Brain-Computer Interface (BCI) Devices Market in Rest of Europe (2022-2032)
  • Table 18: Implanted Brain-Computer Interface (BCI) Devices Market in Asia-Pacific (2022-2032)
  • Table 19: Implanted Brain-Computer Interface (BCI) Devices Market in China (2022-2032)
  • Table 20: Implanted Brain-Computer Interface (BCI) Devices Market in Japan (2022-2032)
  • Table 21: Implanted Brain-Computer Interface (BCI) Devices Market in India (2022-2032)
  • Table 22: Implanted Brain-Computer Interface (BCI) Devices Market in Australia (2022-2032)
  • Table 23: Implanted Brain-Computer Interface (BCI) Devices Market in South Korea (2022-2032)
  • Table 24: Implanted Brain-Computer Interface (BCI) Devices Market in Rest of Asia-Pacific (2022-2032)
  • Table 25: Implanted Brain-Computer Interface (BCI) Devices Market in Rest of the World (2022-2032)
  • Table 26: Implanted Brain-Computer Interface (BCI) Devices Market in the Middle East (2022-2032)
  • Table 27: Implanted Brain-Computer Interface (BCI) Devices Market in Africa (2022-2032)
  • Table 28: Implanted Brain-Computer Interface (BCI) Devices Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Implanted Brain-Computer Interface (BCI) Devices Market in Global (2022-2032)
  • Figure 3: Implanted Brain-Computer Interface (BCI) Devices Market in Global by Product Type (2022-2032)
  • Figure 4: Implanted Brain-Computer Interface (BCI) Devices Market in Global by Approach (2022-2032)
  • Figure 5: Implanted Brain-Computer Interface (BCI) Devices Market in Global by Application (2022-2032)
  • Figure 6: Implanted Brain-Computer Interface (BCI) Devices Market in Global by Geography (2022-2032)
  • Figure 7: Implanted Brain-Computer Interface (BCI) Devices Market in North America (2022-2032)
  • Figure 8: Implanted Brain-Computer Interface (BCI) Devices Market in the United States (2022-2032)
  • Figure 9: Implanted Brain-Computer Interface (BCI) Devices Market in Canada (2022-2032)
  • Figure 10: Implanted Brain-Computer Interface (BCI) Devices Market in Mexico (2022-2032)
  • Figure 11: Implanted Brain-Computer Interface (BCI) Devices Market in Europe (2022-2032)
  • Figure 12: Implanted Brain-Computer Interface (BCI) Devices Market in France (2022-2032)
  • Figure 13: Implanted Brain-Computer Interface (BCI) Devices Market in Germany (2022-2032)
  • Figure 14: Implanted Brain-Computer Interface (BCI) Devices Market in United Kingdom (2022-2032)
  • Figure 15: Implanted Brain-Computer Interface (BCI) Devices Market in Italy (2022-2032)
  • Figure 16: Implanted Brain-Computer Interface (BCI) Devices Market in Spain (2022-2032)
  • Figure 17: Implanted Brain-Computer Interface (BCI) Devices Market in Rest of Europe (2022-2032)
  • Figure 18: Implanted Brain-Computer Interface (BCI) Devices Market in Asia-Pacific (2022-2032)
  • Figure 19: Implanted Brain-Computer Interface (BCI) Devices Market in China (2022-2032)
  • Figure 20: Implanted Brain-Computer Interface (BCI) Devices Market in Japan (2022-2032)
  • Figure 21: Implanted Brain-Computer Interface (BCI) Devices Market in India (2022-2032)
  • Figure 22: Implanted Brain-Computer Interface (BCI) Devices Market in Australia (2022-2032)
  • Figure 23: Implanted Brain-Computer Interface (BCI) Devices Market in South Korea (2022-2032)
  • Figure 24: Implanted Brain-Computer Interface (BCI) Devices Market in Rest of Asia-Pacific (2022-2032)
  • Figure 25: Implanted Brain-Computer Interface (BCI) Devices Market in the Rest of the World (2022-2032)
  • Figure 26: Implanted Brain-Computer Interface (BCI) Devices Market in the Middle East (2022-2032)
  • Figure 27: Implanted Brain-Computer Interface (BCI) Devices Market in Africa (2022-2032)
  • Figure 28: Implanted Brain-Computer Interface (BCI) Devices Market in South America (2022-2032)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis
目次
Product Code: DIMDCL0763

Implanted Brain-Computer Interface (BCI) Devices Market by Product (Hardware and Software), Approach (Invasive BCI and Minimally invasive BCI), Application (Epilepsy, Brain Injury, Depression, Stroke, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2032 owing to the growing prevalence of neurological and movement disorders and increasing technological innovations in BCI devices

The implanted brain-computer interface (BCI) devices market is estimated to grow at a CAGR of 10.42% during the forecast period from 2025 to 2032. The demand for implanted brain-computer interface (BCI) devices is significantly driven by the increasing prevalence of neurological and movement disorders and a rising number of patients experiencing hearing and vision loss. Additionally, the growing adoption of digital health solutions is reshaping the landscape of patient care, further fueling market growth. Key factors contributing to this upward trend include increasing research and development activities and strategic collaborations among leading players to develop more advanced BCI devices. These developments are expected to play a pivotal role in propelling the implanted BCI devices market during the forecast period from 2025 to 2032.

Implanted Brain-Computer Interface (BCI) Devices Market Dynamics:

The rising prevalence of neurological and movement disorders is poised to drive market growth for implanted brain-computer interface (BCI) devices. The data provided by the World Health Organization (WHO) in April 2024, mentioned that approximately 15.4 million people were living with spinal cord injury in 2021 worldwide.

According to data provided by UK Research and Innovation in 2022, approximately 10 million people are affected by traumatic brain injury every year in the world. Implanted BCI devices play a crucial role in evaluating brain function after TBI, offering vital insights into the extent of brain damage and guiding treatment decisions. This increasing incidence of neurological disorders is creating a heightened demand for implanted BCI devices, thereby propelling market growth.

According to recent data from the World Health Organization (WHO) in 2024, approximately 50 million people worldwide were living with epilepsy in 2023, with around 5 million new diagnoses occurring each year, making epilepsy one of the most common neurological disorders globally. As per the same source in 2023, over 55 million people were living with dementia, with more than 60% of these individuals located in low- and middle-income countries. Each year, nearly 10 million new cases are diagnosed on average. Implanted BCIs can monitor brain activity to detect abnormal electrical patterns associated with seizures, providing real-time data that can help manage epilepsy more effectively. Such increasing prevalence of movement disorders is expected to foster the market growth.

The increasing prevalence of hearing and vision loss is anticipated to significantly drive market growth for implanted brain-computer interface (BCI) devices. According to data from the World Health Organization (WHO) in March 2023, over 190 million people in Europe were living with hearing loss, a figure expected to surpass 230 million by 2050. Implanted BCI devices play a crucial role in restoring hearing, providing individuals with improved auditory experiences. As the number of people affected by hearing loss continues to rise, the demand for these innovative BCI devices is set to grow, further propelling market expansion.

Key players increasingly focus on technological innovations to develop advanced implanted brain-computer interface (BCI) devices that integrate cutting-edge technologies. For instance, in November 2022 Blackrock Neurotech, a U.S. based company launched Neuralace(TM). This next-generation neural interface is engineered with diverse materials and patterns to connect with extensive areas of the brain's surface. Neuralace is designed to perform complex functions without relying on assistive technologies, offering groundbreaking solutions for vision and memory restoration, performance prediction, and the treatment of mental health disorders. Such innovative product developments not only enhance the capabilities of BCI devices but also significantly drive market growth.

However, the complications and safety concerns associated with implanted BCI devices and high cost of BCI devices, among others are some of the key constraints that may limit the growth of the implanted brain-computer interface (BCI) devices market.

Implanted Brain-Computer Interface (BCI) Devices Market Segment Analysis:

Implanted Brain-Computer Interface (BCI) Devices Market by Product (Hardware and Software), Approach (Invasive BCI and Minimally invasive BCI), Application (Epilepsy, Brain Injury, Depression, Stroke, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the implanted brain-computer interface (BCI) devices market, the hardware category is estimated to amass a significant revenue share in the implanted brain-computer interface (BCI) devices market in 2024. This trend can be attributed to the rising incidence of patients suffering from strokes and spinal cord injuries worldwide. According to data from the Centers for Disease Control and Prevention (CDC) published in May 2024, over 795,000 individuals in the United States experience a stroke each year. Implanted BCI hardware such as electrodes and sensors are primarily designed to detect brain signals and facilitate communication between the brain and external devices. These BCIs can significantly assist stroke patients in regaining control over their bodies and improving motor functions. The increasing prevalence of strokes and spinal cord injuries is driving segment growth and contributing to the overall expansion of the implanted brain-computer interface (BCI) devices market.

The growth of the brain-computer interface (BCI) segment can also be attributed to the various advantages offered by the hardware utilized in these devices. BCIs have diverse applications in rehabilitation settings, where they play a crucial role in post-stroke or injury recovery. By promoting neuroplasticity, these devices enable patients to regain motor functions through targeted exercises that are controlled by their thoughts. This capability not only accelerates recovery but also empowers patients by facilitating a more intuitive interaction with their rehabilitation process. As awareness of these benefits grows, the demand for advanced BCI solutions in clinical and therapeutic contexts is expected to expand, further driving market growth.

Moreover, increasing research and development activities aimed at developing innovative implantable BCI devices are significantly fueling market growth. A notable example is Synchron's completion of the COMMAND trial in September 2023, which focused on its brain-computer interface (BCI) devices that received Investigational Device Exemption (IDE) from the FDA. The primary objective of this study was to determine the safety of implanting the device within the blood vessels of the brain using neuro-interventional procedures. Such R&D activities by key players are driving the market growth.

North America is expected to dominate the overall implanted brain-computer interface (BCI) devices market:

North America is expected to account for the largest market share in the implanted brain-computer interface (BCI) devices market in 2024, out of all regions. This can be attributed to the rising prevalence of hearing loss and neurological disorders, alongside a growing geriatric population. Additionally, the increasing healthcare awareness and ongoing technological innovations led by key industry players are significantly driving market growth in North America.

The rising prevalence of neurological disorders is a key factor driving market growth in North America. As per data from the Centers for Disease Control and Prevention (CDC) in September 2023, approximately 6.7 million individuals aged 65 and older were living with Alzheimer's disease in 2023, a number projected to increase to 13.9 million by 2060 in the United States.

According to data from the Centers for Disease Control and Prevention (CDC) published in May 2024, approximately 3 million individuals in the United States were living with epilepsy in 2021. Implanted BCI devices provide innovative solutions for rehabilitation and assistive technologies tailored to the needs of these individuals. Consequently, the increasing prevalence of neurological conditions is driving demand for implanted BCI devices, thereby significantly contributing to market growth in the region.

The increasing geriatric population, which is more susceptible to neurological and motor impairments, is significantly driving market growth in the region. According to data from the Population Reference Bureau published in January 2024, there were approximately 58 million individuals aged 65 and older in the United States in 2022, a number projected to rise to 82 million by 2050. As the global demographic of elderly individuals expands, the demand for implanted BCI devices that address age-related cognitive and mobility decline is also on the rise, thereby propelling the market growth.

The increasing focus on product development and launch activities by key players is significantly fostering market growth. For instance, in May 2024, CorTec announced that the FDA approved an Investigational Device Exemption (IDE) application for its closed-loop brain-computer interface (BCI). This innovative device is designed to support novel stroke rehabilitation treatments by utilizing cortical stimulation to enhance neuroplasticity within the brain. Such product development activities by key players are driving market growth in North America.

Implanted Brain-Computer Interface (BCI) Devices Market Key Players:

Some of the key market players operating in the implanted brain-computer interface (BCI) devices market include NeuroPace, Inc., Blackrock Neurotech, Synchron, LivaNova, Inc., BrainGate, BrainCo, Inc., Cognixion, Inc., Brain Products GmbH, Compumedics Neuroscan, CorTec, Snap Inc., g.tec medical engineering GmbH, Bitbrain Technologies, Nexstem India Pvt. Ltd., Paradromics, CereGate, Precision Neuroscience, ONWARD Medical N.V., NeuroSky, NeuroXess, and others.

Recent Developmental Activities in the Implanted Brain-Computer Interface (BCI) Devices Market:

  • In February 2024, Onward Medical secured Breakthrough Device Designation (BDD) from the U.S. Food and Drug Administration (FDA) for its ARC-BCI System. This innovative technology integrates brain-computer interface (BCI) technology with Onward's proprietary ARC-IM(R) Therapy to facilitate thought-driven lower limb mobility restoration in patients with spinal cord injuries (SCI). This designation underscores the potential of the ARC-BCI System to significantly enhance patient outcomes and expedite its development and commercialization process.
  • In May 2023, Neuralink granted an Investigational Device Exemption (IDE) for its N1 Implant. This cutting-edge device is designed to be cosmetically invisible and aimed to record and wirelessly transmit brain signals to a dedicated app that interprets movement intentions. This milestone paves the way for clinical studies and highlights Neuralink's commitment to advancing brain-computer interface technology for enhanced user interaction and mobility.

Key Takeaways from the Implanted Brain-Computer Interface (BCI) Devices Market Report Study

  • Market size analysis for current Implanted Brain-Computer Interface (BCI) Devices Market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global Implanted Brain-Computer Interface (BCI) Devices market.
  • Various opportunities available for the other competitors in the Implanted Brain-Computer Interface (BCI) Devices Market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current Implanted Brain-Computer Interface (BCI) Devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Implanted Brain-Computer Interface (BCI) Devices market growth in the coming future?

Target Audience who can be benefited from this Implanted Brain-Computer Interface (BCI) Devices Market Report Study

  • Implanted Brain-Computer Interface (BCI) Devices product providers
  • Research organizations and consulting companies
  • Implanted Brain-Computer Interface (BCI) Devices related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Implanted Brain-Computer Interface (BCI) Devices
  • Various end-users who want to know more about the Implanted Brain-Computer Interface (BCI) Devices Market and the latest technological developments in the Implanted Brain-Computer Interface (BCI) Devices Market.

Frequently Asked Questions for the Implanted Brain-Computer Interface (BCI) Devices Market:

1. What are Implanted Brain-Computer Interface (BCI) Devices?

  • Implanted brain-computer interface (BCI) devices represent a cutting-edge neurotechnology, engineered to create a direct communication link between the brain and external systems. These sophisticated solutions typically incorporate surgically implanted electrodes or arrays that capture and interpret neuronal activity related to specific cognitive processes, such as movement intention or communication.

2. What is the market for Implanted Brain-Computer Interface (BCI) Devices?

  • The implanted brain-computer interface (BCI) devices market is estimated to grow at a CAGR of 10.42% during the forecast period from 2025 to 2032.

3. What are the drivers for the Implanted Brain-Computer Interface (BCI) Devices market?

  • The implanted brain-computer interface (BCI) devices market is experiencing significant growth due to several key factors such as the increasing prevalence of neurological and movement disorders and a rising number of patients experiencing hearing and vision loss. Additionally, the growing adoption of digital health solutions is reshaping the landscape of patient care, further fuelling market growth. Key factors contributing to this upward trend include increasing research and development activities and strategic collaborations among leading players to develop more advanced BCI devices.

4. Who are the key players operating in the Implanted Brain-Computer Interface (BCI) Devices market?

  • Some of the key market players operating in the implanted brain-computer interface (BCI) devices market include NeuroPace, Inc., Blackrock Neurotech, Synchron, LivaNova, Inc., BrainGate, BrainCo, Inc., Cognixion, Inc., Brain Products GmbH, Compumedics Neuroscan, CorTec, Snap Inc., g.tec medical engineering GmbH, Bitbrain Technologies, Nexstem India Pvt. Ltd., Paradromics, CereGate, Precision Neuroscience, ONWARD Medical N.V., NeuroSky, NeuroXess, and others.

5. Which region has the highest share in the Implanted Brain-Computer Interface (BCI) Devices market?

  • North America is expected to account for the largest market share in the implanted brain-computer interface (BCI) devices market in 2024, out of all regions. This can be attributed to the rising prevalence of hearing loss and neurological disorders, alongside a growing geriatric population. Additionally, increasing healthcare awareness and ongoing technological innovations led by key industry players are significantly driving market growth in North America.

Table of Contents

1. Implanted Brain-Computer Interface (BCI) Devices Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Implanted Brain-Computer Interface (BCI) Devices Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Implanted Brain-Computer Interface (BCI) Devices Market Key Factors Analysis

  • 5.1. Implanted Brain-Computer Interface (BCI) Devices Market Drivers
    • 5.1.1. The increasing prevalence of neurological and movement disorders
    • 5.1.2. Rising number of patients experiencing hearing and vision loss
    • 5.1.3. The growing adoption of digital health solutions
    • 5.1.4. Increasing research and development activities and strategic collaborations among leading players
  • 5.2. Implanted Brain-Computer Interface (BCI) Devices Market Restraints and Challenges
    • 5.2.1. Complications and safety concerns associated with implanted BCI devices
    • 5.2.2. High cost of these devices
  • 5.3. Implanted Brain-Computer Interface (BCI) Devices Market Opportunity
    • 5.3.1. Integration of artificial intelligence (AI) with Implanted BCI devices
    • 5.3.2. Emergence of minimally invasive surgeries and smart implants

6. Implanted Brain-Computer Interface (BCI) Devices Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Implanted Brain-Computer Interface (BCI) Devices Market Assessment

  • 7.1. By Product
    • 7.1.1. Hardware
    • 7.1.2. Software
  • 7.2. By Approach
    • 7.2.1. Invasive BCI
    • 7.2.2. Minimally invasive BCI
  • 7.3. By Application
    • 7.3.1. Epilepsy
    • 7.3.2. Brain Injury
    • 7.3.3. Depression
    • 7.3.4. Stroke
    • 7.3.5. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.1.2. Canada Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.1.3. Mexico Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
    • 7.4.2. Europe
      • 7.4.2.1. France Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.2.2. Germany Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.2.3. United Kingdom Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.2.4. Italy Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.2.5. Spain Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.2.6. Rest of Europe Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.3.2. Japan Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.3.3. India Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.3.4. Australia Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.3.5. South Korea Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
      • 7.4.3.6. Rest of Asia-Pacific Implanted Brain-Computer Interface (BCI) Devices Market Size in USD million (2022-2032)
    • 7.4.4. Rest of the World (RoW)

8. Implanted Brain-Computer Interface (BCI) Devices Market Company and Product Profiles

  • 8.1. NeuroPace, Inc.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Blackrock Neurotech
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Synchron
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. LivaNova, Inc.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. BrainGate
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. BrainCo, Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Cognixion, Inc.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Brain Products GmbH
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Compumedics Neuroscan
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. CorTec
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Snap Inc.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. g.tec medical engineering GmbH
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Bitbrain Technologies
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Nexstem India Pvt. Ltd.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Paradromics
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. CereGate
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Precision Neuroscience
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. ONWARD Medical N.V.
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. NeuroSky
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. NeuroXess
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us